Tissue Engineering Market to Grow with a CAGR of 9.24% through 2028
Rising biotechnology breakthroughs and personalized
medicine are expected to drive the Global Tissue Engineering Market growth in
the forecast period, 2024-2028.
According to TechSci Research report, “Tissue
Engineering Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2028”, the Global Tissue Engineering Market
stood at USD 11.26 billion in 2022 and is anticipated to grow with a CAGR of 9.24%
in the forecast period, 2024-2028. The Global Tissue Engineering Market is
experiencing significant growth, driven by a convergence of factors that are
transforming the healthcare landscape. Tissue engineering, a multidisciplinary
field that combines biology, chemistry, and engineering principles to create
functional tissues and organs for medical purposes, has gained prominence due
to the increasing demand for regenerative medicine solutions. One of the
primary drivers of the tissue engineering market is the escalating prevalence
of chronic diseases and injuries worldwide. Conditions such as cardiovascular
diseases, diabetes, orthopedic disorders, and spinal cord injuries affect
millions of people globally. Traditional treatment approaches often fall short in
providing lasting solutions. Tissue engineering offers a ray of hope by
enabling the development of patient-specific tissues and organs that can
replace or repair damaged or dysfunctional ones. As these health issues
continue to rise, the demand for tissue engineering solutions grows, driving
market expansion.
Advancements in biotechnology, biomaterials, and 3D
printing technologies are at the forefront of tissue engineering's growth.
These technological breakthroughs have expanded the capabilities of researchers
and companies in creating complex, functional tissues that closely mimic
natural structures. The integration of stem cell research, gene editing
techniques such as CRISPR-Cas9, and the development of biocompatible materials
have ushered in a new era of tissue engineering. These innovations enhance the
success rates of transplants and reduce the risk of rejection, further fueling
market growth. The tissue engineering market benefits from a wide
array of applications across various medical fields. It extends beyond basic
tissue repair to encompass areas such as skin grafts, bone and cartilage
regeneration, heart valve replacement, and even the creation of whole organs
like kidneys and livers. This diversity in applications makes tissue
engineering an invaluable tool for addressing medical challenges across
multiple specialties, contributing to its steady market growth.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Tissue Engineering Market.”
The global demographic landscape is shifting, with a
rapidly aging population in many regions. Aging is often accompanied by a
higher incidence of age-related diseases and degenerative conditions, leading
to a greater need for medical interventions. Tissue engineering addresses this
need by providing innovative therapies that can enhance the quality of life for
older individuals. The ability to create personalized tissues and organs
tailored to the unique needs of elderly patients is a significant market
driver.
The Global Tissue Engineering Market is segmented into
Material Type, Application, End-user, Regional Distribution, And Company.
Based on the Material Type, the Biologically Derived
Materials emerged as the dominant segment in the global market for Global
Tissue Engineering Market in 2022. Biomaterials closely mimic the body's
natural extracellular matrix, promoting cell adhesion and tissue integration
without triggering adverse immune responses. These materials provide a
substrate for cell attachment, proliferation, and differentiation, enabling the
formation of new tissues. Many biologically derived materials are
biodegradable, gradually breaking down as the newly generated tissue takes over
the structural role, reducing the need for additional surgeries to remove
implant materials. Biomaterials can be selected or modified to match the
specific mechanical, biochemical, and structural properties required for
different tissues and applications. In some cases, biologically derived
materials can be sourced from the patient's own tissues or from donor tissues,
reducing the risk of rejection compared to synthetic materials.
Based on the Application,
the Orthopedics segment emerged as the dominant player in the global market for
Global Tissue Engineering Market in 2022. The demand for tissue engineering
solutions in orthopedics, musculoskeletal, and spine-related applications is
driven by the high prevalence of these conditions, especially in aging
populations. As the world's demographics shift towards an older population, the
incidence of musculoskeletal conditions and age-related orthopedic issues is on
the rise. Consequently, there is a growing need for innovative therapies like
tissue engineering to address these health concerns effectively. Moreover,
tissue engineering in orthopedics and spine applications aligns with the trend
of personalized medicine. Patient-specific tissue constructs, created using the
individual's own cells or tailored to their unique anatomy, offer a higher
likelihood of successful outcomes, reduced risk of rejection, and improved
long-term functionality.
Based on the End User, the Hospitals segment emerged
as the dominant player in the global market for Global Tissue Engineering
Market in 2022. Hospitals are at the forefront of patient care and treatment.
Tissue engineering products, such as tissue-engineered skin for burn victims,
bone grafts for orthopedic patients, or tissue-engineered heart valves for
cardiac patients, are commonly used in hospital settings to provide advanced
medical solutions to patients with various medical conditions. Hospitals often
serve as sites for clinical trials and research studies involving tissue
engineering. These trials evaluate the safety and efficacy of new
tissue-engineered products and therapies, further driving demand for tissue
engineering technologies. Hospitals provide easy accessibility to patients in
need of tissue engineering interventions. Patients with conditions requiring
tissue repair or replacement often seek treatment in hospital settings, where
they can benefit from the latest tissue engineering advancements.
North America emerged as the dominant player in the
global Tissue Engineering Market in
2022, holding the largest market share. North America boasts a highly developed
healthcare infrastructure, comprising state-of-the-art hospitals, research
centers, and academic institutions. This advanced infrastructure facilitates
the adoption of tissue engineering technologies and their integration into
clinical practice.
The region is a hub for cutting-edge research and
development in the field of tissue engineering. Leading universities, research
institutes, and biotechnology companies conduct extensive research, driving
innovation and the development of new tissue-engineered products and therapies.
Major companies operating in Global Tissue
Engineering Market are:
- Zimmer Biomet
Holdings Inc.
- Stryker Corporation
Holdings
- 3D BioFibR Inc.
- Integra LifeSciences
Corporation
- CollPlant
Biotechnologies Ltd.
- AbbVie (Allergan Aesthetics)
- Becton, Dickinson
and Company
- Athersys, Inc.
- BioTissue
- Japan Tissue
Engineering Co., Ltd
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The Global
Tissue Engineering Market is poised for substantial growth in the coming years,
driven by a convergence of factors that underscore its significance in the
field of regenerative medicine. With an aging population and rising incidence
of chronic diseases and injuries, the demand for innovative tissue engineering
solutions continues to surge. Technological advancements, including
biotechnology breakthroughs, gene editing techniques, and 3D printing, are
unlocking new possibilities and enhancing the success rates of tissue
engineering applications. Additionally, the trend toward personalized medicine
aligns seamlessly with tissue engineering's capacity to create patient-specific
tissues and organs. Regulatory support and increasing investments in research
and development are further fueling the market's expansion..” said Mr. Karan
Chechi, Research Director with TechSci Research, a research-based management
consulting firm.
“Tissue Engineering Market - Global Industry
Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Material
Type (Synthetic Materials, Biologically Derived Materials, Others), By
Application (Orthopedics, Musculoskeletal & Spine, Neurology, Cardiology,
Skin & Integumentary, Others), By End User (Hospitals, Cancer Research
Centers, Academic and Research Institutes, Others) By Region and Competition”, has evaluated
the future growth potential of Global Tissue Engineering Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Tissue Engineering Market.
Contact
Mr. Ken
Mathews
708 Third
Avenue,
Manhattan, NY,
New York –
10017
Tel:
+1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com